CHRO Chromocell Therapeutics Corp: Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik chromocell.com (CHRO)

The development of non-opioid analgesics by Chromocell Therapeutics (CHRO) is not subject to economic cycles or seasonality. The EV-to-revenue multiple demonstrates the market consensus, where the metric reflects current dynamics. The company is implementing energy saving and emission filtration in its laboratories. Stable demand for neuro-innovations makes this asset a reliable defensive tool, independent of global macro shocks.

Chromocell Therapeutics Corp - Nilai perusahaan marang pendapatan CHRO (periode 04.07.2022 - 20.11.2026)

chromocell.com - rincian analitis lan metrik utama (CHRO)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Chromocell Therapeutics CHRO
Sampel barang Chromocell Therapeutics

This indicator determines the market value of the business minus net debt divided by annual sales, allowing for an assessment of revenue capitalization efficiency without the influence of debt load. By analyzing the enterprise value-to-revenue chart on GURU.Markets, an investor can compare market expectations for the development of non-opioid analgesics by Chromocell Therapeutics (CHRO) with the costs of implementing green chemistry and bioethics principles.

Analisis pesaing Chromocell Therapeutics

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|NRSN - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales RVPH (Reviva Pharmaceuticals Holdings Inc.)|Koefisien nilai perusahaan marang pendapatan MTVA (metaviatx.com)|NeurAxis Inc. - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan heliusmedical.com HSDT|PASG: Multiplikator EV/Sales|Neuphoria - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NERV|ATHA: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCN (cyclerion.com)|Rasio nilai perusahaan marang dodolan Protagenic|KTTA: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan CRGT (cortigent.com)|ATXI: Multiplikator EV/Sales|BCLI (BrainStorm Cell Therapeutics) - Rasio nilai perusahaan marang pendapatan|CARA (Cara Therapeutics Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE